José Moltó

Co–infection of<i>Mycobacterium tuberculosis</i>and<i>Mycobacterium leprae</i>in human archaeological samples: a possible explanation for the historical decline of leprosy

Helen D. Donoghue, Antónia Marcsik, Carney Matheson et al. · Proceedings of the Royal Society B Biological Sciences · 2005 · 188 citations · Full text

Life Sciences, Immunology, Microbiology +15

Long-Term Neuropsychiatric Disorders on Efavirenz-Based Approaches

Carmina R. Fumaz, José A. Muñoz-Moreno, José Moltó et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 156 citations

Medicine, Pharmacology, Psychiatry +16

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

Eugènia Negredo, Marta Massanella, Jordi Puig et al. · Clinical Infectious Diseases · 2010 · 152 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

Eugènia Negredo, José Moltó, David M. Burger et al. · AIDS · 2004 · 114 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Measurement of Intracellular Didanosine and Tenofovir Phosphorylated Metabolites and Possible Interaction of the Two Drugs in Human Immunodeficiency Virus-Infected Patients

Alain Pruvost, Eugènia Negredo, Henri Bénech et al. · Antimicrobial Agents and Chemotherapy · 2005 · 111 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15